The global liquid biopsy market, poised for significant growth, benefits from increased demand for non-invasive cancer ...

The rise in chronic diseases, especially cancer, fuels demand for early, non-invasive diagnostics offered by EV-based liquid biopsies. Key growth opportunities lie in the development of sensitive ...

The market for minimally invasive biopsy techniques is driven by growing cancer prevalence, patient preference for less ...

This growth is primarily driven by the rising global cancer incidence, increasing preference for non-invasive diagnostic ...

Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...

Healthcare has outperformed tech and is among the top performing stock sector in the last three months. Here are one ETF ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Non-Cancer Liquid Biopsy Testing Market - A Global and Regional Analysis: Focus on Application, Technology, End User, and Regional Analysis - Analysis ...

'Liquid biopsies' are quick, accurate and repeatable - and they're already save lives ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...